Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2831364rdf:typepubmed:Citationlld:pubmed
pubmed-article:2831364lifeskim:mentionsumls-concept:C0037380lld:lifeskim
pubmed-article:2831364lifeskim:mentionsumls-concept:C0003015lld:lifeskim
pubmed-article:2831364lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2831364lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:2831364lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:2831364lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:2831364lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:2831364pubmed:issue3lld:pubmed
pubmed-article:2831364pubmed:dateCreated1988-4-11lld:pubmed
pubmed-article:2831364pubmed:abstractTextTwo ketomethylene-containing nonapeptide analogues were synthesized to determine if ketomethylene analogues of the nonapeptide venom inhibitors of angiotensin converting enzyme (ACE) would have oral ACE inhibition activity. Both ketomethylene-containing nonapeptides 18 and 19 were potent inhibitors of rabbit lung ACE with I50s of 3.4 and 8.0 nM, respectively, compared to 340 nM for their parent nonapeptide and 450 nM for captopril. Peptide 18 was rapidly cleaved by trypsin, but 19 was reasonably stable to all enzyme degradation systems tested with maximum degradation of 50% by pepsin in 3 h. Both 18 and 19 when given iv to normotensive rats were between 3 and 10 times more potent than captopril in inhibiting an angiotensin I induced blood pressure increase. Peptide 19 showed no ACE inhibition activity in unanesthetized normotensive rats when administered orally at doses of 10 or 100 mg/kg. Experiments were conducted to determine whether 19 is adsorbed from the gastrointestinal track following oral administration. These experiments indicated that 19 is adsorbed. It is concluded that the lack of oral activity of 19 is probably due to its rapid excretion, probably into the bile.lld:pubmed
pubmed-article:2831364pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2831364pubmed:languageenglld:pubmed
pubmed-article:2831364pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2831364pubmed:citationSubsetIMlld:pubmed
pubmed-article:2831364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2831364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2831364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2831364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2831364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2831364pubmed:statusMEDLINElld:pubmed
pubmed-article:2831364pubmed:monthMarlld:pubmed
pubmed-article:2831364pubmed:issn0022-2623lld:pubmed
pubmed-article:2831364pubmed:authorpubmed-author:ChaoW RWRlld:pubmed
pubmed-article:2831364pubmed:authorpubmed-author:PanasevichR...lld:pubmed
pubmed-article:2831364pubmed:authorpubmed-author:MitomaCClld:pubmed
pubmed-article:2831364pubmed:authorpubmed-author:AlmquistR GRGlld:pubmed
pubmed-article:2831364pubmed:authorpubmed-author:JuddA KAKlld:pubmed
pubmed-article:2831364pubmed:authorpubmed-author:MatthewsR JRJlld:pubmed
pubmed-article:2831364pubmed:authorpubmed-author:RossiD JDJlld:pubmed
pubmed-article:2831364pubmed:issnTypePrintlld:pubmed
pubmed-article:2831364pubmed:volume31lld:pubmed
pubmed-article:2831364pubmed:ownerNLMlld:pubmed
pubmed-article:2831364pubmed:authorsCompleteYlld:pubmed
pubmed-article:2831364pubmed:pagination561-7lld:pubmed
pubmed-article:2831364pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:meshHeadingpubmed-meshheading:2831364-...lld:pubmed
pubmed-article:2831364pubmed:year1988lld:pubmed
pubmed-article:2831364pubmed:articleTitleSynthesis and biological activity of ketomethylene-containing nonapeptide analogues of snake venom angiotensin converting enzyme inhibitors.lld:pubmed
pubmed-article:2831364pubmed:affiliationLife Sciences, SRI International, Menlo Park, California 94025.lld:pubmed
pubmed-article:2831364pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2831364pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2831364lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2831364lld:pubmed